论文部分内容阅读
目的分析尤瑞克林对进展性脑卒中患者神经功能缺损的干预作用。方法应用随机双盲法将100例进展性脑卒中患者分为两组,每组50例,对照组采取常规治疗,观察组在对照组基础上加用尤瑞克林治疗,比较两组临床疗效、不良反应及治疗前后神经功能缺损评分。结果观察组治疗总有效率为94.0%,治疗后NIHSS评分(12.2±4.6)分,与对照组的76.0%、(16.7±4.3)分比较差异有统计学意义(P<0.05)。两组均无明显不良反应发生。结论尤瑞克林能明显减轻进展性脑卒中患者神经功能缺损症状,疗效明确且不良反应少,安全有效。
Objective To analyze the intervention of uracil on neurological deficits in patients with progressive stroke. Methods 100 patients with progressive stroke were divided into two groups by randomized double-blind method, 50 cases in each group. The control group was treated by conventional therapy. The observation group was treated with urelin based on the control group. The clinical efficacy , Adverse reactions and neurological deficits before and after treatment. Results The total effective rate of the observation group was 94.0%. The NIHSS score (12.2 ± 4.6) after treatment was significantly lower than that of the control group (76.0%, 16.7 ± 4.3) (P <0.05). No significant adverse reactions occurred in both groups. Conclusion Youre Kelin can significantly reduce the symptoms of neurological deficits in patients with progressive stroke, clear effect and less adverse reactions, safe and effective.